Skip to content

503A vs 503B: Key Differences for Providers in Washington DC

Compounding pharmacies serving Washington DC operate under two distinct regulatory frameworks in the United States: Section 503A and Section 503B of the Federal Food, Drug, and Cosmetic Act. While both models exist to support Washington DC patients when commercially available medications are not suitable, they differ in scale, regulatory structure, and clinical application. Each pathway serves a different purpose in supporting patient care in Washington DC, and understanding when to use each can help Washington DC providers make more informed sourcing decisions.